GENE ONLINE|News &
Opinion
Blog

Autoimmune Disease
Funding Autoimmune Disease
Netherlands-based Argenx Raises $1.1 Billion in Global Offering Following Success in Clinical Trials
2023-07-23
M&A MerckAutoimmune Disease
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Trials & Approvals IgA Nephropathy
Vera Therapeutics Eyes Phase 3 For Kidney Disease Candidate Following Positive Data
2023-01-04
Special biopharmam&a
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
M&A Autoimmune Disease
Vallon and GRI Bio Strike a Merger Deal, Joining Forces for Innovative NKT Cell Regulators
2022-12-14
Trials & Approvals AstraZeneca
Japan Approves AstraZeneca’s Complement Inhibitor For Rare Muscle Disorder
2022-08-26
Trials & Approvals Autoimmune Disease
Takeda Announces Positive Topline From Pivotal Trial For Autoimmune Disease
2022-07-25
Special 2022 Single Cell Sequencing
How Single Cell Sequencing is Advancing Biomedical Research
2022-07-15
R&D Autoimmune Disease
New Mitochondrial Response Pathway May Advance Treatments for Inflammatory Diseases
2022-07-14
Licensing Autoimmune Disease
AbbVie & Cugene Join Forces to Tackle Autoimmune Diseases
2022-05-17
China Autoimmune
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Trials & Approvals Sanofi
Sanofi’ Enjaymo Wins FDA Approval for Rare Autoimmune Anemia
2022-02-07
Funding Autoimmune Disease
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
Funding Cell Therapy
Mozart Therapeutics Makes Play with $55 Million Series A to Capitalize on Novel Tregs Pathway
2021-10-27
Funding
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
1 2
LATEST
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
Advancements in Alzheimer’s Disease Drug Innovation and Funding Programs in 2024
2024-07-04
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
BIO Asia–Taiwan 2024 Set to Showcase Global Biotech Industry Talent on July 24th
2024-07-03
Novo Nordisk’s CLARION-CKD Trial Shut Down After Unsuccessful Results Causing Impairment Loss
2024-07-03
Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market
2024-07-03
Ginkgo Job Cuts Expected to Affect at Least 35% of Workforce, Eliminating Over 400 Jobs
2024-07-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top